• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱天冬酶介导的造血祖细胞激酶1(HPK1)裂解将核因子κB的激活剂转化为核因子κB的抑制剂。

Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB.

作者信息

Arnold R, Liou J, Drexler H C, Weiss A, Kiefer F

机构信息

Max-Planck Institute for Physiological and Clinical Research, W. G. Kerckhoff Institute, Parkstrasse 1, D-61231 Bad Nauheim, Germany.

出版信息

J Biol Chem. 2001 May 4;276(18):14675-84. doi: 10.1074/jbc.M008343200. Epub 2001 Jan 29.

DOI:10.1074/jbc.M008343200
PMID:11278403
Abstract

Hematopoietic progenitor kinase 1 (HPK1), a mammalian Ste20-related protein kinase, is a potent stimulator of the stress-activated protein kinases (SAPKs/JNKs). Here we report activation of NFkappaB transcription factors by HPK1 that was independent of SAPK/JNK activation. Overexpression of a dominant-negative SEK1 significantly inhibited SAPK/JNK activation, whereas NFkappaB stimulation by HPK1 remained unaffected. Furthermore, activation of NFkappaB required the presence of full-length, kinase-active HPK1, whereas the isolated kinase domain of HPK1 was sufficient for activation of SAPK/JNK. We also demonstrate that overexpression of a dominant-negative IKKbeta blocks HPK1-mediated NFkappaB activation suggesting that HPK1 acts upstream of the IkappaB kinase complex. In apoptotic myeloid progenitor cells HPK1 was cleaved at a DDVD motif resulting in the release of the kinase domain and a C-terminal part. Although expression of the isolated HPK1 kinase domain led to SAPK/JNK activation, the C-terminal part inhibited NFkappaB activation. This dominant-negative effect was not only restricted to HPK1-mediated but also to NIK- and tumor necrosis factor alpha-mediated NFkappaB activation, suggesting an impairment of the IkappaB kinase complex. Thus HPK1 activates both the SAPK/JNK and NFkappaB pathway in hematopoietic cells but is converted into an inhibitor of NFkappaB activation in apoptotic cells.

摘要

造血祖细胞激酶1(HPK1)是一种与哺乳动物Ste20相关的蛋白激酶,是应激激活蛋白激酶(SAPKs/JNKs)的有效刺激物。在此我们报告,HPK1可激活NFκB转录因子,且该激活独立于SAPK/JNK的激活。显性负性SEK1的过表达显著抑制了SAPK/JNK的激活,而HPK1对NFκB的刺激作用不受影响。此外,NFκB的激活需要全长、具有激酶活性的HPK1的存在,而HPK1的分离激酶结构域足以激活SAPK/JNK。我们还证明,显性负性IKKβ的过表达可阻断HPK1介导的NFκB激活,这表明HPK1在IκB激酶复合物的上游起作用。在凋亡的髓系祖细胞中,HPK1在DDVD基序处被切割,导致激酶结构域和C末端部分的释放。尽管分离的HPK1激酶结构域的表达导致了SAPK/JNK的激活,但C末端部分抑制了NFκB的激活。这种显性负性作用不仅限于HPK1介导的,也包括NIK和肿瘤坏死因子α介导的NFκB激活,提示IκB激酶复合物受损。因此,HPK1在造血细胞中激活了SAPK/JNK和NFκB两条途径,但在凋亡细胞中转变为NFκB激活的抑制剂。

相似文献

1
Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB.半胱天冬酶介导的造血祖细胞激酶1(HPK1)裂解将核因子κB的激活剂转化为核因子κB的抑制剂。
J Biol Chem. 2001 May 4;276(18):14675-84. doi: 10.1074/jbc.M008343200. Epub 2001 Jan 29.
2
Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade.人HPK1,一种可激活JNK/SAPK激酶级联反应的新型人造血祖细胞激酶。
Genes Dev. 1996 Sep 15;10(18):2251-64. doi: 10.1101/gad.10.18.2251.
3
HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.造血蛋白激酶1,一种激活应激激活蛋白激酶/应激活化蛋白激酶通路的激酶。
EMBO J. 1996 Dec 16;15(24):7013-25.
4
Activation of hematopoietic progenitor kinase-1 by erythropoietin.促红细胞生成素对造血祖细胞激酶-1的激活作用。
Blood. 1999 May 15;93(10):3347-54.
5
NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain.NIK是一种新的与Ste20相关的激酶,它与NCK和MEKK1结合,并通过一个保守的调节结构域激活SAPK/JNK级联反应。
EMBO J. 1997 Mar 17;16(6):1279-90. doi: 10.1093/emboj/16.6.1279.
6
Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1).半胱天冬酶介导的造血祖细胞激酶1(HPK1)的切割与功能变化
Oncogene. 1999 Dec 2;18(51):7370-7. doi: 10.1038/sj.onc.1203116.
7
Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.造血祖细胞激酶1的激活涉及蛋白激酶D1介导的重新定位、自身磷酸化和转磷酸化。
Mol Cell Biol. 2005 Mar;25(6):2364-83. doi: 10.1128/MCB.25.6.2364-2383.2005.
8
Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase.造血祖细胞激酶1与衔接蛋白Crk和CrkL的相互作用导致c-Jun氨基末端激酶的协同激活。
Mol Cell Biol. 1999 Feb;19(2):1359-68. doi: 10.1128/MCB.19.2.1359.
9
Interaction of hematopoietic progenitor kinase 1 and c-Abl tyrosine kinase in response to genotoxic stress.造血祖细胞激酶1与c-Abl酪氨酸激酶在基因毒性应激反应中的相互作用。
J Biol Chem. 2001 May 25;276(21):18130-8. doi: 10.1074/jbc.M007294200. Epub 2001 Jan 30.
10
Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.HPK1对NFκB的激活或抑制决定了对激活诱导的细胞死亡的敏感性。
EMBO J. 2005 Dec 21;24(24):4279-90. doi: 10.1038/sj.emboj.7600894. Epub 2005 Dec 8.

引用本文的文献

1
HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders.HPK1激酶抑制剂:与降解剂相比,靶向HPK1以调节癌症免疫治疗中T细胞活化的一种有效方法。
Front Immunol. 2025 Feb 6;16:1449106. doi: 10.3389/fimmu.2025.1449106. eCollection 2025.
2
An updated review of small-molecule HPK1 kinase inhibitors (2016-present).小分子HPK1激酶抑制剂的最新综述(2016年至今)。
Future Med Chem. 2024;16(22):2431-2450. doi: 10.1080/17568919.2024.2420630. Epub 2024 Nov 25.
3
HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics.
HPK1 柠檬酸基结构域调节 SLP76 的磷酸化,调节激酶结构域相互作用动态。
Nat Commun. 2024 May 2;15(1):3725. doi: 10.1038/s41467-024-48014-9.
4
The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.激酶 MAP4K1 通过促进 TBK1/IKKε 的蛋白酶体降解来抑制细胞质 RNA 诱导的抗病毒信号。
Microbiol Spectr. 2021 Dec 22;9(3):e0145821. doi: 10.1128/Spectrum.01458-21. Epub 2021 Dec 15.
5
A perspective on HPK1 as a novel immuno-oncology drug target.HPK1 作为一种新型免疫肿瘤学药物靶点的观点。
Elife. 2020 Sep 8;9:e55122. doi: 10.7554/eLife.55122.
6
The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.Hippo-YAP 通路与固有免疫的串扰。
Front Immunol. 2020 Feb 27;11:323. doi: 10.3389/fimmu.2020.00323. eCollection 2020.
7
Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.造血祖细胞激酶 1 下调胰腺癌中的致癌受体酪氨酸激酶 AXL。
J Biol Chem. 2020 Feb 21;295(8):2348-2358. doi: 10.1074/jbc.RA119.012186. Epub 2020 Jan 20.
8
Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation.与舒尼替尼复合物中 HPK1 激酶结构域的多种构象状态揭示了伴随 HPK1 反式调控的结构变化。
J Biol Chem. 2019 Jun 7;294(23):9029-9036. doi: 10.1074/jbc.AC119.007466. Epub 2019 Apr 24.
9
The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity.蛋白磷酸酶2A调节亚基B56γ介导对T细胞受体(TCR)诱导的核因子κB(NF-κB)活性的抑制。
J Biol Chem. 2014 May 23;289(21):14996-5004. doi: 10.1074/jbc.M113.533547. Epub 2014 Apr 9.
10
The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.CUL7/F-box 和 WD 重复结构域包含 8(CUL7/Fbxw8)泛素连接酶促进造血祖细胞激酶 1 的降解。
J Biol Chem. 2014 Feb 14;289(7):4009-17. doi: 10.1074/jbc.M113.520106. Epub 2013 Dec 20.